White blood cell count predicts infarct size in STEMI

White blood cell count predicts infarct size in STEMI

(HealthDay)—For patients with anterior wall ST-segment elevated myocardial infarction (STEMI), elevated white blood cell count (WBCc) on presentation is associated with increased infarct size, according to a study published in the Dec. 15 issue of The American Journal of Cardiology.

Tullio Palmerini, M.D., from Policlinico S. Orsola in Bologna, Italy, and colleagues examined whether elevated WBCc correlates with increased infarct size measured with cardiac 30 days after primary . Data were from 407 participants with STEMI and proximal or mid-left anterior descending coronary artery occlusion from the Intracoronary Abciximab and Aspiration Thrombectomy in Patients With Large Anterior Myocardial Infarction trial. Participants were stratified according to WBCc tertiles.

The researchers observed an increase in infarct size (percentage of total left ventricular mass) at 30 days across tertiles of increasing WBCcs (median for tertiles I versus II versus III, 11.2 versus 17.5 versus 19.1 percent; P < 0.0001). Across tertiles of WBCc, absolute infarct mass in grams and abnormal wall motion score also increased significantly. WBCc independently predicted infarct size in multivariate analysis, together with intracoronary abciximab randomization, age, time from onset of symptoms to first device, proximal left anterior descending location, and baseline Thrombolysis In Myocardial Infarction flow of 0/1.

"In conclusion, in patients with anterior wall STEMI, an elevated admission WBCc is a powerful independent predictor of infarct size measured with cardiac magnetic resonance imaging 30 days after primary percutaneous coronary intervention," the authors write.

Two authors disclosed financial ties to the medical device industry.

More information: Abstract
Full Text (subscription or payment may be required)

add to favorites email to friend print save as pdf

Related Stories

Results of the CHILL-MI trial presented

Oct 31, 2013

A clinical trial shows that rapidly cooling patients who have suffered ST-elevation myocardial infarction (STEMI, the most serious form of a heart attack) prior to restoring blood flow is safe and feasible. The findings of ...

Results of the TATORT-NSTEMI trial presented

Nov 01, 2013

According to a new study, aspirating blood clots does not significantly reduce microvascular obstruction or reduce the risk of death in patients with non-ST-elevation myocardial infarction (NSTEMI), when compared to standard ...

Recommended for you

Pay-for-performance not found to impact access to CABG

1 hour ago

(HealthDay)—For patients with acute myocardial infarction (AMI), treatment at pay-for-performance (P4P) hospitals is not associated with a change in the rate of coronary artery bypass graft (CABG) surgery, ...

A prescription for better stroke care

8 hours ago

Stroke patients are 70 per cent more likely to continue taking their stroke prevention medications one year later if they have a prescription in hand when discharged – according to researchers at St. Michael's ...

User comments